Zhang Huan, Li Wenhua, Fu Caixia, Grimm Robert, Chen Zhiyu, Zhang Wen, Qiu Lixin, Wang Chenchen, Zhang Xiaowei, Yue Lei, Hu Xiaoxin, Guo Weijian, Tong Tong
Department of Radiology, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Eur J Radiol. 2020 Sep;130:109149. doi: 10.1016/j.ejrad.2020.109149. Epub 2020 Jun 26.
To assess the usefulness and performance of intravoxel incoherent motion imaging (IVIM) with diffusion kurtosis imaging (DKI) and conventional DWI for predicting the chemotherapeutic response of colorectal liver metastases (CRLMs).
A prospective study was conducted. Up to February 2018, forty consecutive patients treated with the standard first-line chemotherapy regimens were enrolled. MRI was performed within 1 week before chemotherapy, as well as 2-3 weeks and 6-8 weeks after chemotherapy. The apparent diffusion coefficient map, IVIM and DKI parameter maps were calculated using a prototype postprocessing software. The response was assessed by the Response Evaluation Criteria in Solid Tumors. The parameters were compared between the responding group (complete and partial response) and the nonresponding group (stable and progressive disease).
A total of 15 responding and 25 nonresponding patients were evaluated. Low baseline ADC, D, and D values (P = 0.001, <0.001, and =0.003, respectively) and a high baseline K value (P = 0.002) were independently associated with a good response to chemotherapy. The combination of all the significant parameters yielded an AUC of 0.867. After treatment, the ADC, D, and D values all showed an upward trend, while the K value showed a decreasing trend, but there were no significant differences (P > 0.05).
The study showed that the pretreatment IVIM (D), DKI (D and K), and conventional DWI (ADC) parameters all demonstrated a good diagnostic performance in predicting the chemotherapeutic response of CRLMs.
评估体素内不相干运动成像(IVIM)联合扩散峰度成像(DKI)及传统扩散加权成像(DWI)预测结直肠癌肝转移(CRLMs)化疗反应的有效性和性能。
进行一项前瞻性研究。截至2018年2月,连续纳入40例接受标准一线化疗方案治疗的患者。在化疗前1周内以及化疗后2 - 3周和6 - 8周进行磁共振成像(MRI)检查。使用原型后处理软件计算表观扩散系数图、IVIM和DKI参数图。根据实体瘤疗效评价标准评估反应情况。比较反应组(完全缓解和部分缓解)与无反应组(疾病稳定和进展)之间的参数。
共评估了15例反应患者和25例无反应患者。低基线表观扩散系数(ADC)、扩散系数(D)和扩散峰度系数(D)值(分别为P = 0.001、<0.001和 = 0.003)以及高基线峰度值(K)(P = 0.002)与化疗的良好反应独立相关。所有显著参数的组合得出的曲线下面积(AUC)为0.867。治疗后,ADC、D和D值均呈上升趋势,而K值呈下降趋势,但差异无统计学意义(P > 0.05)。
该研究表明,治疗前的IVIM(D)、DKI(D和K)以及传统DWI(ADC)参数在预测CRLMs化疗反应方面均表现出良好的诊断性能。